[1] C. Cagnoli, G. Stevanin, A. Brussino, M. Barberis, C. Mancini, R.L. Margolis, S.E. Holmes, M. Nobili, S. Forlani, S. Padovan, P. Pappi, C. Zaros, I. Leber, P. Ribai, L. Pugliese, C. Assalto, A. Brice, N. Migone, A. Durr, A. Brusco, Missense mutations in the AFG3L2 proteolytic domain account for approximately 1.5% of European autosomal dominant cerebellar ataxias, Hum Mutat 31(10) (2010) 1117-24.
[2] G.S. Gorman, G. Pfeffer, H. Griffin, E.L. Blakely, M. Kurzawa-Akanbi, J. Gabriel, K. Sitarz, M. Roberts, B. Schoser, A. Pyle, A.M. Schaefer, R. McFarland, D.M. Turnbull, R. Horvath, P.F. Chinnery, R.W. Taylor, Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28, JAMA Neurol 72(1) (2015) 106-11.
[3] L. Szpisjak, V.L. Nemeth, N. Szepfalusi, D. Zadori, Z. Maroti, T. Kalmar, L. Vecsei, P. Klivenyi, Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation, Cerebellum 16(5-6) (2017) 979-985.
[4] C. Cagnoli, C. Mariotti, F. Taroni, M. Seri, A. Brussino, C. Michielotto, M. Grisoli, D. Di Bella, N. Migone, C. Gellera, S. Di Donato, A. Brusco, SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2, Brain 129(Pt 1) (2006) 235-42.
[5] U. Edener, J. Wollner, U. Hehr, Z. Kohl, S. Schilling, F. Kreuz, P. Bauer, V. Bernard, G. Gillessen-Kaesbach, C. Zuhlke, Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation, Eur J Hum Genet 18(8) (2010) 965-8.
[6] S. Tunc, M. Dulovic-Mahlow, H. Baumann, M.K. Baaske, M. Jahn, J. Junker, A. Munchau, N. Bruggemann, K. Lohmann, Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2, Cerebellum 18(4) (2019) 817-822.
[7] M. Manto, D. Marmolino, Cerebellar ataxias, Curr Opin Neurol 22(4) (2009) 419-29.
[8] G. Coarelli, A. Brice, A. Durr, Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view, F1000Res 7 (2018).
[9] Y.M. Sun, C. Lu, Z.Y. Wu, Spinocerebellar ataxia: relationship between phenotype and genotype - a review, Clin Genet 90(4) (2016) 305-14.
[10] M.U. Manto, The wide spectrum of spinocerebellar ataxias (SCAs), Cerebellum 4(1) (2005) 2-6.
[11] D. Di Bella, F. Lazzaro, A. Brusco, M. Plumari, G. Battaglia, A. Pastore, A. Finardi, C. Cagnoli, F. Tempia, M. Frontali, L. Veneziano, T. Sacco, E. Boda, A. Brussino, F. Bonn, B. Castellotti, S. Baratta, C. Mariotti, C. Gellera, V. Fracasso, S. Magri, T. Langer, P. Plevani, S. Di Donato, M. Muzi-Falconi, F. Taroni, Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28, Nat Genet 42(4) (2010) 313-21.
[12] P.M. Quiros, T. Langer, C. Lopez-Otin, New roles for mitochondrial proteases in health, ageing and disease, Nat Rev Mol Cell Biol 16(6) (2015) 345-59.
[13] M. Nolden, S. Ehses, M. Koppen, A. Bernacchia, E.I. Rugarli, T. Langer, The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria, Cell 123(2) (2005) 277-89.
[14] L. Atorino, L. Silvestri, M. Koppen, L. Cassina, A. Ballabio, R. Marconi, T. Langer, G. Casari, Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia, J Cell Biol 163(4) (2003) 777-87.
[15] F. Maltecca, E. Baseggio, F. Consolato, D. Mazza, P. Podini, S.M. Young, Jr., I. Drago, B.A. Bahr, A. Puliti, F. Codazzi, A. Quattrini, G. Casari, Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model, J Clin Invest 125(1) (2015) 263-74.
[16] J. Qu, C.K. Wu, J.R. Zuzuarregui, A.D. Hohler, A novel AFG3L2 mutation in a Somalian patient with spinocerebellar ataxia type 28, Journal of the neurological sciences 358(1-2) (2015) 530-1.
[17] Z. Musova, M. Kaiserova, E. Kriegova, R. Fillerova, P. Vasovcak, A. Santava, K. Mensikova, A. Zumrova, A. Krepelova, Z. Sedlacek, P. Kanovsky, A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia, Cerebellum 13(3) (2014) 331-7.
[18] K. Smets, T. Deconinck, J. Baets, A. Sieben, J.J. Martin, I. Smouts, S. Wang, F. Taroni, D. Di Bella, W. Van Hecke, P.M. Parizel, C. Jadoul, R. De Potter, F. Couvreur, E. Rugarli, P. De Jonghe, Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28, Neurology 82(23) (2014) 2092-100.
[19] C. Mariotti, A. Brusco, D. Di Bella, C. Cagnoli, M. Seri, C. Gellera, S. Di Donato, F. Taroni, Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis, Cerebellum 7(2) (2008) 184-8.
[20] A. Brussino, A. Brusco, A. Durr, C. Mancini, Spinocerebellar Ataxia Type 28, in: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya (Eds.), GeneReviews((R)), Seattle (WA), 1993.
[21] H.A.G. Teive, W.O. Arruda, Cognitive dysfunction in spinocerebellar ataxias, Dement Neuropsychol 3(3) (2009) 180-187.
[22] V.M. Miller, H. Xia, G.L. Marrs, C.M. Gouvion, G. Lee, B.L. Davidson, H.L. Paulson, Allele-specific silencing of dominant disease genes, Proceedings of the National Academy of Sciences of the United States of America 100(12) (2003) 7195-200.